{"id":332527,"date":"2026-10-29T14:53:02","date_gmt":"2026-10-29T09:23:02","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=332527"},"modified":"2026-10-29T14:53:02","modified_gmt":"2026-10-29T09:23:02","slug":"largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Largecap Profit Cagr Higher Than Revenue Cagr Stocks to Watch for Future Multibagger Potential: Sun Pharma, HAL, TVS Motor and Eicher Motors"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Sun Pharma Rs 1,757.50. HAL Rs 4,850. TVS Motor Rs 4,239.90. Eicher Motors Rs 7,300. Market caps from Rs 2.00 lakh crore to Rs 4.22 lakh crore. Data as of 28 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Sun Pharma, HAL, TVS Motor and Eicher Motors are the 4 picks in this profit cagr higher than revenue cagr stocks watchlist, with market caps between Rs 2.00 lakh crore and Rs 4.22 lakh crore. Sun Pharma stands out for the largest market cap at Rs 4,22,307 crore, while HAL offers the biggest five-year price gain at 607.71%. PE ratios run from 34.64 to 56.67, so compare each one with its industry PE before investing. All figures are as of 28 October 2026.<\/p>\n<\/p><\/div>\n<p>Profit cagr higher than revenue cagr stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Sun Pharma, HAL, TVS Motor and Eicher Motors meet that test, with market caps from Rs 2.00 lakh crore to Rs 4.22 lakh crore and Sun Pharma offering the largest market cap at Rs 4,22,307 crore. Each of these companies has a four year profit CAGR at least 5 percentage points above the four year revenue CAGR, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.<\/p>\n<p>This list covers companies with a four year profit CAGR at least 5 percentage points above the four year revenue CAGR, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening profit cagr higher than revenue cagr stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=profit-cagr-higher-than-revenue-cagr-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#What_Are_Profit_Cagr_Higher_Than_Revenue_Cagr_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Profit Cagr Higher Than Revenue Cagr Stocks and Why Do They Attract Multibagger Interest?\">What Are Profit Cagr Higher Than Revenue Cagr Stocks and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#Profit_Cagr_Higher_Than_Revenue_Cagr_Stocks_at_a_Glance_Price_Market_Cap_PE_ROE_and_Price_to_Book\" title=\"Profit Cagr Higher Than Revenue Cagr Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book\">Profit Cagr Higher Than Revenue Cagr Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#Sun_Pharma_3575_Profit_CAGR_Since_FY22\" title=\"Sun Pharma: 35.75% Profit CAGR Since FY22\">Sun Pharma: 35.75% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#HAL_Return_on_Equity_of_2221\" title=\"HAL: Return on Equity of 22.21%\">HAL: Return on Equity of 22.21%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#TVS_Motor_4450_Profit_CAGR_Since_FY22\" title=\"TVS Motor: 44.50% Profit CAGR Since FY22\">TVS Motor: 44.50% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#Eicher_Motors_3467_Profit_CAGR_Since_FY22\" title=\"Eicher Motors: 34.67% Profit CAGR Since FY22\">Eicher Motors: 34.67% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#Profit_Cagr_Higher_Than_Revenue_Cagr_Stocks_Financial_Comparison_on_Growth_and_Margins\" title=\"Profit Cagr Higher Than Revenue Cagr Stocks: Financial Comparison on Growth and Margins\">Profit Cagr Higher Than Revenue Cagr Stocks: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#Institutional_Holding_in_Sun_Pharma_HAL_TVS_Motor_and_Eicher_Motors\" title=\"Institutional Holding in Sun Pharma, HAL, TVS Motor and Eicher Motors\">Institutional Holding in Sun Pharma, HAL, TVS Motor and Eicher Motors<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Profit_Cagr_Higher_Than_Revenue_Cagr_Stocks\" title=\"Risks to Weigh in Profit Cagr Higher Than Revenue Cagr Stocks\">Risks to Weigh in Profit Cagr Higher Than Revenue Cagr Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#How_to_Choose_Between_Profit_Cagr_Higher_Than_Revenue_Cagr_Stocks\" title=\"How to Choose Between Profit Cagr Higher Than Revenue Cagr Stocks\">How to Choose Between Profit Cagr Higher Than Revenue Cagr Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Profit_Cagr_Higher_Than_Revenue_Cagr_Stocks_to_Watch\" title=\"Frequently Asked Questions on Profit Cagr Higher Than Revenue Cagr Stocks to Watch\">Frequently Asked Questions on Profit Cagr Higher Than Revenue Cagr Stocks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#Which_are_the_best_profit_cagr_higher_than_revenue_cagr_stocks_to_watch_for_multibagger_potential\" title=\"Which are the best profit cagr higher than revenue cagr stocks to watch for multibagger potential?\">Which are the best profit cagr higher than revenue cagr stocks to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#Is_TVS_Motor_a_good_stock_for_long-term_investors\" title=\"Is TVS Motor a good stock for long-term investors?\">Is TVS Motor a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#Can_Sun_Pharma_become_a_multibagger_from_here\" title=\"Can Sun Pharma become a multibagger from here?\">Can Sun Pharma become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Sun_Pharma_HAL_TVS_Motor_and_Eicher_Motors\" title=\"What is the market cap of Sun Pharma, HAL, TVS Motor and Eicher Motors?\">What is the market cap of Sun Pharma, HAL, TVS Motor and Eicher Motors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_profit_cagr_higher_than_revenue_cagr_stocks\" title=\"What are the risks of investing in profit cagr higher than revenue cagr stocks?\">What are the risks of investing in profit cagr higher than revenue cagr stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#Why_is_TVS_Motor_trading_at_a_PE_of_5667\" title=\"Why is TVS Motor trading at a PE of 56.67?\">Why is TVS Motor trading at a PE of 56.67?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Sun_Pharma_HAL_TVS_Motor_and_Eicher_Motors\" title=\"How much do institutions hold in Sun Pharma, HAL, TVS Motor and Eicher Motors?\">How much do institutions hold in Sun Pharma, HAL, TVS Motor and Eicher Motors?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Profit_Cagr_Higher_Than_Revenue_Cagr_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Profit Cagr Higher Than Revenue Cagr Stocks and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Profit cagr higher than revenue cagr stocks are shares of large companies whose profit has compounded faster than their sales over the last four years, a clear sign of widening margins and rising efficiency. The four here cover pharmaceuticals, aerospace and defence, two wheelers and motorcycles.<\/p>\n<p>When profit grows faster than sales year after year, the company is keeping more from every rupee it earns, which is the base for lasting returns. For profit cagr higher than revenue cagr stocks, both FY26 and the latest quarter showed growth. Whichever way you read profit cagr higher than revenue cagr stocks, the common thread is rising profit backed by complete financial data. Investors researching profit cagr higher than revenue cagr stocks get a fuller picture by reading growth and valuation together. The table below lines up profit cagr higher than revenue cagr stocks on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use profit cagr higher than revenue cagr stocks as a starting point for your own research.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Profit_Cagr_Higher_Than_Revenue_Cagr_Stocks_at_a_Glance_Price_Market_Cap_PE_ROE_and_Price_to_Book\"><\/span><strong>Profit Cagr Higher Than Revenue Cagr Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 28 October 2026. Eicher Motors has the lowest PE of the group at 34.64, while TVS Motor posts the highest return on equity at 31.56%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Price to Book<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\">Sun Pharmaceutical Industries<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,757.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,22,307<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.85<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.74%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.05<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,583.70 to 2,046.90<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/hal\/hindustan-aeronautics-ltd-share-price-today\">Hindustan Aeronautics<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,850<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,31,342<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">35.55<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">48.59<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.21%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.08<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,479.10 to 5,149.90<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/tvsmotor\/tvs-motor-company-ltd-share-price-today\">TVS Motor Company<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">4,239.90<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,04,088<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">56.67<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.62<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">31.56%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.27<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,228.00 to 4,484.50<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/eichermot\/eicher-motors-ltd-share-price-today\">Eicher Motors<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7,300<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,99,994<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.64<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.82<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.97%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7.97<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6,442.00 to 8,230.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Sun_Pharma_3575_Profit_CAGR_Since_FY22\"><\/span><strong>Sun Pharma: 35.75% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Sun Pharmaceutical Industries is one of India&#8217;s largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026. The stock trades at a PE of 34.85 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"HAL_Return_on_Equity_of_2221\"><\/span><strong>HAL: Return on Equity of 22.21%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Hindustan Aeronautics is India&#8217;s state-owned aerospace company that designs, makes and services fighter jets, helicopters, engines and avionics. It reported FY26 revenue of Rs 36,787.95 crore, up 9.68% year on year, and net profit of Rs 9,115.52 crore, up 8.98%. Net profit has compounded at 15.74% a year since FY22, while revenue has grown 9.48% a year. Operating margin was 40.89% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 35.55 against an industry PE of 48.59, below the sector average, with a return on equity of 22.21%. In the June 2026 quarter, revenue rose 15.26% to Rs 6,415.41 crore and net profit grew 14.88% to Rs 1,589.66 crore. The share price has gained 607.71% over five years. Domestic institutions raised their holding from 8.71% in September 2025 to 12.56% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"TVS_Motor_4450_Profit_CAGR_Since_FY22\"><\/span><strong>TVS Motor: 44.50% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>TVS Motor Company makes motorcycles, scooters, mopeds and electric two-wheelers, with a growing export business. It reported FY26 revenue of Rs 56,091.53 crore, up 27.02% year on year, and net profit of Rs 3,186.43 crore, up 35.60%. Net profit has compounded at 44.50% a year since FY22, while revenue has grown 23.15% a year. Operating margin was 14.85% in FY26.<\/p>\n<p>In the June 2026 quarter, revenue rose 34.32% to Rs 16,453.72 crore and net profit grew 64.52% to Rs 1,057.61 crore. The share price has gained 598.75% over five years and 14.49% over the past year. Domestic institutions raised their holding from 18.81% in June 2025 to 21.13% in June 2026. The stock trades at a PE of 56.67 against an industry PE of 23.62, with a return on equity of 31.56%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Eicher_Motors_3467_Profit_CAGR_Since_FY22\"><\/span><strong>Eicher Motors: 34.67% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Eicher Motors owns the Royal Enfield brand of premium motorcycles and is a partner in the Eicher commercial vehicle business. It reported FY26 revenue of Rs 24,894.09 crore, up 23.39% year on year, and net profit of Rs 5,515.23 crore, up 16.49%. Net profit has compounded at 34.67% a year since FY22, while revenue has grown 23.39% a year. Operating margin was 34.24% in FY26. The debt-to-equity ratio is 0.02, which keeps interest costs low.<\/p>\n<p>The stock trades at a PE of 34.64 against an industry PE of 23.82, with a return on equity of 21.97%. In the June 2026 quarter, revenue rose 29.35% to Rs 7,098.73 crore and net profit grew 21.35% to Rs 1,462.51 crore. The share price has gained 174.76% over five years.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Profit_Cagr_Higher_Than_Revenue_Cagr_Stocks_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Profit Cagr Higher Than Revenue Cagr Stocks: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these profit cagr higher than revenue cagr stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Net Profit CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">61,673.94<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11,564.52<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.69%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11.62%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">35.75%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">32.52%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">HAL<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36,787.95<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9,115.52<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.68%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.48%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.74%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">44.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">TVS Motor<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">56,091.53<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,186.43<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">27.02%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.15%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">44.50%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Eicher Motors<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24,894.09<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5,515.23<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.39%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.39%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.67%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">34.28%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these profit cagr higher than revenue cagr stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Sun_Pharma_HAL_TVS_Motor_and_Eicher_Motors\"><\/span><strong>Institutional Holding in Sun Pharma, HAL, TVS Motor and Eicher Motors<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these profit cagr higher than revenue cagr stocks alongside the promoter. The table uses the latest reported quarter for each. Eicher Motors has the deepest institutional backing, with FII and DII together holding 41.59% as of June 2026. Domestic institutions increased their holding over the past year in Sun Pharma (from 20.23% to 22.27%), HAL (from 8.71% to 12.56%) and TVS Motor (from 18.81% to 21.13%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Sun Pharma<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.68%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.27%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">10.70%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">HAL<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">71.64%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.42%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">12.56%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6.38%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">TVS Motor<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">50.27%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.45%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">21.13%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.15%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Eicher Motors<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">49.02%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25.53%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.06%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9.40%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Profit_Cagr_Higher_Than_Revenue_Cagr_Stocks\"><\/span><strong>Risks to Weigh in Profit Cagr Higher Than Revenue Cagr Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with profit cagr higher than revenue cagr stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past growth may not repeat.<\/li>\n<li>Share prices can move sharply in either direction.<\/li>\n<li><strong>Valuation:<\/strong> TVS Motor trades at a PE of 56.67 against an industry PE of 23.62, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Profit_Cagr_Higher_Than_Revenue_Cagr_Stocks\"><\/span><strong>How to Choose Between Profit Cagr Higher Than Revenue Cagr Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from profit cagr higher than revenue cagr stocks comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (23.62 to 48.59) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the operating margin and the return on equity in every quarterly result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Sun Pharma, HAL, TVS Motor and Eicher Motors live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among profit cagr higher than revenue cagr stocks, Sun Pharma stands out for the largest market cap at Rs 4,22,307 crore, HAL for the biggest five-year price gain at 607.71%, TVS Motor for the highest return on equity at 31.56% and Eicher Motors for the lowest PE of the group at 34.64. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing profit cagr higher than revenue cagr stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Profit_Cagr_Higher_Than_Revenue_Cagr_Stocks_to_Watch\"><\/span><strong>Frequently Asked Questions on Profit Cagr Higher Than Revenue Cagr Stocks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_profit_cagr_higher_than_revenue_cagr_stocks_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best profit cagr higher than revenue cagr stocks to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sun Pharma, HAL, TVS Motor and Eicher Motors are the 4 names this list highlights, with market caps of Rs 4,22,307 crore, Rs 3,31,342 crore, Rs 2,04,088 crore and Rs 1,99,994 crore respectively. Sun Pharma is notable for the largest market cap at Rs 4,22,307 crore. HAL stands out for the biggest five-year price gain at 607.71%. TVS Motor offers the highest return on equity at 31.56%. Eicher Motors brings the lowest PE of the group at 34.64. These are watchlist names for profit cagr higher than revenue cagr stocks, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_TVS_Motor_a_good_stock_for_long-term_investors\"><\/span><strong>Is TVS Motor a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> TVS Motor has a return on equity of 31.56%, a PE of 56.67 against an industry PE of 23.62 and a market cap of Rs 2,04,088 crore. Net profit has compounded at 44.50% a year since FY22, and FY26 revenue rose 27.02% while June 2026 quarter net profit grew 64.52%. Long-term returns in profit cagr higher than revenue cagr stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Sun_Pharma_become_a_multibagger_from_here\"><\/span><strong>Can Sun Pharma become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in profit cagr higher than revenue cagr stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.85 against an industry PE of 36.42, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Sun_Pharma_HAL_TVS_Motor_and_Eicher_Motors\"><\/span><strong>What is the market cap of Sun Pharma, HAL, TVS Motor and Eicher Motors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 28 October 2026, Sun Pharma has a market cap of Rs 4,22,307 crore, HAL has a market cap of Rs 3,31,342 crore, TVS Motor has a market cap of Rs 2,04,088 crore and Eicher Motors has a market cap of Rs 1,99,994 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on profit cagr higher than revenue cagr stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_profit_cagr_higher_than_revenue_cagr_stocks\"><\/span><strong>What are the risks of investing in profit cagr higher than revenue cagr stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. TVS Motor trades at a PE of 56.67 against an industry PE of 23.62, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_TVS_Motor_trading_at_a_PE_of_5667\"><\/span><strong>Why is TVS Motor trading at a PE of 56.67?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> TVS Motor&#8217;s PE of 56.67 compares with an industry PE of 23.62. The market is paying a premium for a return on equity of 31.56%, profit growth of 44.50% a year since FY22 and latest-quarter profit growth of 64.52%, which also means the stock is more sensitive if growth slows. Investors in profit cagr higher than revenue cagr stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Sun_Pharma_HAL_TVS_Motor_and_Eicher_Motors\"><\/span><strong>How much do institutions hold in Sun Pharma, HAL, TVS Motor and Eicher Motors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 36.63% of Sun Pharma (14.36% and 22.27%), 21.98% of HAL (9.42% and 12.56%), 41.58% of TVS Motor (20.45% and 21.13%) and 41.59% of Eicher Motors (25.53% and 16.06%). Rising institutional holding is a useful signal in profit cagr higher than revenue cagr stocks, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best profit cagr higher than revenue cagr stocks to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sun Pharma, HAL, TVS Motor and Eicher Motors are the 4 names this list highlights, with market caps of Rs 4,22,307 crore, Rs 3,31,342 crore, Rs 2,04,088 crore and Rs 1,99,994 crore respectively. Sun Pharma is notable for the largest market cap at Rs 4,22,307 crore. HAL stands out for the biggest five-year price gain at 607.71%. TVS Motor offers the highest return on equity at 31.56%. Eicher Motors brings the lowest PE of the group at 34.64. These are watchlist names for profit cagr higher than revenue cagr stocks, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is TVS Motor a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"TVS Motor has a return on equity of 31.56%, a PE of 56.67 against an industry PE of 23.62 and a market cap of Rs 2,04,088 crore. Net profit has compounded at 44.50% a year since FY22, and FY26 revenue rose 27.02% while June 2026 quarter net profit grew 64.52%. Long-term returns in profit cagr higher than revenue cagr stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Sun Pharma become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in profit cagr higher than revenue cagr stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.85 against an industry PE of 36.42, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Sun Pharma, HAL, TVS Motor and Eicher Motors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 28 October 2026, Sun Pharma has a market cap of Rs 4,22,307 crore, HAL has a market cap of Rs 3,31,342 crore, TVS Motor has a market cap of Rs 2,04,088 crore and Eicher Motors has a market cap of Rs 1,99,994 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on profit cagr higher than revenue cagr stocks.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in profit cagr higher than revenue cagr stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. TVS Motor trades at a PE of 56.67 against an industry PE of 23.62, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is TVS Motor trading at a PE of 56.67?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"TVS Motor's PE of 56.67 compares with an industry PE of 23.62. The market is paying a premium for a return on equity of 31.56%, profit growth of 44.50% a year since FY22 and latest-quarter profit growth of 64.52%, which also means the stock is more sensitive if growth slows. Investors in profit cagr higher than revenue cagr stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Sun Pharma, HAL, TVS Motor and Eicher Motors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 36.63% of Sun Pharma (14.36% and 22.27%), 21.98% of HAL (9.42% and 12.56%), 41.58% of TVS Motor (20.45% and 21.13%) and 41.59% of Eicher Motors (25.53% and 16.06%). Rising institutional holding is a useful signal in profit cagr higher than revenue cagr stocks, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 largecap profit cagr higher than revenue cagr stocks compared on market cap, PE, ROE, growth and institutional holding: Sun Pharma, HAL, TVS Motor and Eicher Motors.<\/p>\n","protected":false},"author":33,"featured_media":332526,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[18221,18220],"class_list":["post-332527","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-profit-cagr-higher-than-revenue-cagr-sector","tag-profit-cagr-higher-than-revenue-cagr-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["332526"],"rank_math_title":["Profit Cagr Higher Than Revenue Cagr Stocks 2026: Sun Pharma, HAL"],"rank_math_description":["Profit cagr higher than revenue cagr stocks to watch for multibagger potential: Sun Pharma, HAL, TVS Motor and Eicher Motors. Compare market cap, PE, ROE and growth."],"rank_math_focus_keyword":["profit cagr higher than revenue cagr stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-largecap-profit-cagr-higher-than-revenue-cagr-stocks-to-watch-for-future.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/332527","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=332527"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/332527\/revisions"}],"predecessor-version":[{"id":332528,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/332527\/revisions\/332528"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/332526"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=332527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=332527"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=332527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}